Deaths Raise Bar for Risk Assessment, FDA Warns Spectranetics

The GMP Letter
A A
The FDA has warned laser sheath maker Spectranetics that patient deaths should have raised the bar on its risk assessment activities.

To View This Article:

Login

Subscribe To The GMP Letter